Delayed versus Immediate Cord Clamping in Preterm InfantsWilliam Tarnow‐Mordi, David G. Sweet, Anthony Keech et al.|New England Journal of Medicine|2017Cited by 304
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutationSubotheni Thavaneswaran, David M. Thomas, Frank Lin et al.|npj Precision Oncology|2024Cited by 6
Genomic Therapy Matching in Rare and Refractory CancersFrank P. Lin, Emily Collignon, Subotheni Thavaneswaran et al.|JAMA Oncology|2026Cited by 6
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid HemangioendotheliomaGregory M. Coté, David M. Thomas, Mason Aberoumand et al.|Clinical Cancer Research|2026Cited by 3
Trastuzumab emtansine (T-DM1) in advanced cancers with <i>HER2 </i>mutations or amplification: Results from the Molecular Screening and Therapeutics (MoST) Program substudy.Subotheni Thavaneswaran, David M. Thomas, Antony Mersiades et al.|Journal of Clinical Oncology|2023Cited by 2